Navigation Links
Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
Date:4/22/2010

HARBIN, China, April 22 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the Company has significantly reduced its Days Sales Outstanding ("DSO"), resulting in improved cash flow from operations and healthier working capital.

For fiscal year 2009, Renhuang reported Days Sales Outstanding of 185 days. At the end of first quarter of 2010, through a variety of management initiatives, the Company effectively reduced its DSO to 117 days. Renhuang's management expects to further lower the DSO period to 100 days by the second quarter, an improvement of over 15% compared with the first quarter and over 46% compared with fiscal year 2009. Management anticipates continued improvement in Days Sales Outstanding in the coming quarters.

The Company's growing sales have contributed to the improvement in DSO. In the past, Renhuang extended special credit terms to its sales agents in order to promote sales. These favorable terms often included lengthy payment periods, resulting in longer Days Sales Outstanding. With the Company's improved position within the pharmaceuticals industry, it is no longer necessary for Renhuang to extend such favorable credit terms and current arrangements have significantly compressed payment periods.

"We continue to focus on strengthening our balance sheet and financial condition, more importantly our accounts receivables. The effective reduction in our DSO, reflects Renhuang's ability to manage risk and demonstrates improvement in our sales management," commented Mr. Shaoming Li, the Chai
'/>"/>

SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results
2. Renhuang Announces Price Increase on Shengmai Granules
3. Renhuang Announces Fiscal Year 2010 Guidance
4. Celator(R) Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms at the American Association for Cancer Research
5. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
6. Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
7. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
8. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
10. Poniard Pharmaceuticals Announces $6.3 Million Financing
11. MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and NEW YORK and ... As the leading distributor of market intelligence, MarketResearch.com is ... report by IQ4I Research and Consultancy focusing on the ... more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)...  goBalto, Inc., the leading provider of cloud-based clinical ... of Red Herring,s Top 100 Global award. ... award in 2013, marking its emergence as a top ... Herring,s Top 100 Global list has become a mark ... Red Herring editors were among the first to recognize ...
(Date:11/26/2014)... 25, 2014 Nanomix Inc., (Nanomix), ... development of mobile diagnostic tests to enable ... and pre-hospital settings, today announced it has ... The certification was awarded by the British ... leading certification bodies. ISO ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Nanomix Receives ISO 13485:2003 Certification 2
(Date:11/28/2014)... Dr. Andrew Campbell, one of the ... of Quintessa Aesthetic Center into a third location in ... N1497 Golf Road in Suite 200 and will open ... new Delafield location will offer a variety of ... filler injectables , micro laser peels, chemical peels, ...
(Date:11/28/2014)... November 28, 2014 Secura Consultants, ... few insurance marketing organizations in the country focused ... asset protection marketplace. Secura Consultants is proud to ... Principal Financial Group, a leading global financial company. ... interests. With the ownership interest comes the need ...
(Date:11/28/2014)... November 28, 2014 Not only is ... products free of petroleum, parabens and other cancer-causing agents, ... fund research, education and awareness programs that help in ... and owners have raised an incredible, record-breaking contribution of ... Cure, sales of the Sweet Red Rose Whip Moisturizer ...
(Date:11/28/2014)... York (PRWEB) November 28, 2014 ... ) have now been filed in a New ... metal implants, Bernstein Liebhard LLP reports. , ... Bergen County Superior Court reflects the filing of ... modular-neck hip stems, which were voluntarily recalled on ...
(Date:11/28/2014)... "Most of my life, I have suffered ... said an inventor from Findlay, Ohio. "I thought that there ... my foot, which inspired me to invent this accessory." , ... way to support an injured foot. The sling makes it ... need for crutches. The design redistributes weight so that the ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3
... works, the greater his chances for high blood pressure, a new ... at the// University of California, Irvine analyzed more than 24,000 people ... found that people who worked 40 hours a week are 14 ... who work under 39 hours a week. Those who work 41 ...
... from Rensselaer Polytechnic Institute in Troy, N.Y., and the University ... the host receptors where anthrax toxin attaches in the body. ... bind to multiple sites on the host receptor making it ... site. The researchers found that the new approach led ...
... doctors were stranded for days at the Charity Hospital, when ... of the storm, Charles Gibson reports from that hospital. ... might think you're in a warehouse or some kind of ... ,Charity Hospital served the poor and uninsured people ...
... conjoined twins were separated after a lengthy surgery. 3 weeks ... to their father, it is an indication of their recovery., ... were conjoined at the trunk and shared several internal organs, ... various medical complications caused by the only kidney, the surgery ...
... draw a little closer in understanding the evolution of the ... be more infectious to people. ,According to ... influenza strains from the common human influenza. This conclusion follows ... type flu viruses. This analysis will also aid scientists trace ...
... the Northern Territory Government’s decision to fund rotavirus ... to follow suit and help// protect vulnerable children ... came after the Federal Government’s Pharmaceutical Benefits Advisory ... cost-effective to provide the rotavirus vaccine to all ...
Cached Medicine News:Health News:Inhibitor That Blocks Host Receptors Found To be Effective In Treating Anthrax 2Health News:Conjoined twins doing well after separation 2Health News:Understanding the Evolution of Viruses a little more Clearly 2
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
... offers strength and radiolucent capabilities for ... titanium microdiscectomy system for microscope-aided repair ... less invasive procedures with reduced patient ... provide low profile, unobstructed retraction capabilities ...
Valin Hemilaminectomy Retractor, self retaining with rack and pinion action....
Karlin Crank Frame Spinal Retractor Set is designed for posterior lumbar and thoracic spine surgery. Arm design allows the blades be pre-positioned in the wound prior to attachment....
Medicine Products: